Giacomini P, Mottolese M, Fraioli R, Benevolo M, Venturo I, Natali P G
Department of Pathology, Regina Elena Institute, Rome, Italy.
Br J Cancer. 1992 Aug;66(2):342-4. doi: 10.1038/bjc.1992.267.
Antigenic modulation of major histocompatibility and tumour associated antigens was observed in neoplastic cells obtained from patients with pleural and abdominal effusions of breast and ovary carcinomas following a single intracavitary dose of 18 x 10(6) U recombinant IFN-alpha. This regimen resulted in antigenic modulation in seven out of 11 tested cases, suggesting a potential, although limited, responsiveness of at least a fraction of breast and ovary carcinoma cells to in situ biomodification with IFN-alpha.
在接受单次腔内注射18×10⁶ U重组干扰素α后,从乳腺癌和卵巢癌胸腔积液及腹腔积液患者获取的肿瘤细胞中观察到主要组织相容性抗原和肿瘤相关抗原的抗原调制。该治疗方案在11例受试病例中有7例导致了抗原调制,这表明至少一部分乳腺癌和卵巢癌细胞对干扰素α原位生物修饰具有潜在的(尽管有限)反应性。